Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.48 SEK | 0.00% | -5.95% | +29.37% |
Mar. 13 | CombiGene's Epilepsy Project CG01 Receives Patent in Two New Countries | CI |
Feb. 21 | Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI). | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
6.35M | - | - | - | - | - | |
111B | ||||||
105B | ||||||
21.93B | - | |||||
22.34B | - | |||||
18.59B |
- Stock Market
- Equities
- COMBI Stock
- Charts CombiGene AB
- Sector Chart